BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10341541)

  • 1. Neuroleptic malignant syndrome associated with olanzapine therapy.
    Apple JE; Van Hauer G
    Psychosomatics; 1999; 40(3):267-8. PubMed ID: 10341541
    [No Abstract]   [Full Text] [Related]  

  • 2. Olanzapine and neuroleptic malignant syndrome.
    Tofler I
    Psychosomatics; 2002; 43(6):505-6; author reply 506. PubMed ID: 12444237
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neuroleptic malignant syndrome and atypical antipsychotics].
    Canora Lebrato J; Bermúdez García JM; Alvarez García ML; Rico Irles J
    Med Clin (Barc); 2000 Sep; 115(7):279. PubMed ID: 11013157
    [No Abstract]   [Full Text] [Related]  

  • 4. Olanzapine-induced neuroleptic malignant syndrome.
    Burkhard PR; Vingerhoets FJ; Alberque C; Landis T
    Arch Gen Psychiatry; 1999 Jan; 56(1):101-2. PubMed ID: 9892264
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine-induced neuroleptic malignant syndrome with mental retardation.
    Margolese HC; Chouinard G
    Am J Psychiatry; 1999 Jul; 156(7):1115-6. PubMed ID: 10401467
    [No Abstract]   [Full Text] [Related]  

  • 6. Possible neuroleptic malignant syndrome associated with olanzapine.
    Nyfort-Hansen K; Alderman CP
    Ann Pharmacother; 2000 May; 34(5):667. PubMed ID: 10852098
    [No Abstract]   [Full Text] [Related]  

  • 7. Olanzapine and NMS.
    Hickey C; Stewart C; Lippmann S
    Psychiatr Serv; 1999 Jun; 50(6):836-7. PubMed ID: 10375159
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome and low-dose olanzapine.
    Suh H; Bronson B; Martin R
    Am J Psychiatry; 2003 Apr; 160(4):796. PubMed ID: 12668376
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine usage associated with neuroleptic malignant syndrome.
    Philibert RA; Adam LA; Frank FM; Carney-Doebbeling C
    Psychosomatics; 2001; 42(6):528-9. PubMed ID: 11815691
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuropletic malignant syndrome and olanzapine.
    Sierra-Biddle D; Herran A; Diez-Aja S; Gonzalez-Mata JM; Vidal E; Diez-Manrique F; Vazquez-Barquero JL
    J Clin Psychopharmacol; 2000 Dec; 20(6):704-5. PubMed ID: 11106147
    [No Abstract]   [Full Text] [Related]  

  • 11. Atypical antipsychotics and neuroleptic malignant syndrome.
    Kohen D; Bristow MF
    Br J Psychiatry; 1999 Oct; 175():392-3. PubMed ID: 10789314
    [No Abstract]   [Full Text] [Related]  

  • 12. Olanzapine associated weight gain, hyperglycemia and neuroleptic malignant syndrome: case report.
    Malyuk R; Gibson B; Procyshyn RM; Kang N
    Int J Geriatr Psychiatry; 2002 Apr; 17(4):326-8. PubMed ID: 11994885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of neuroleptic malignant syndrome with olanzapine treatment.
    Gheorghiu S; Knobler HY; Drumer D
    Am J Psychiatry; 1999 Nov; 156(11):1836. PubMed ID: 10553758
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neuroleptic malignant syndrome associated with olanzapine].
    García López MM; Ciprés L; de Cendra E; Vilalta Franch J
    Med Clin (Barc); 1999 Sep; 113(6):239. PubMed ID: 10472615
    [No Abstract]   [Full Text] [Related]  

  • 15. Olanzapine induced neuroleptic malignant syndrome--a case review.
    Kogoj A; Velikonja I
    Hum Psychopharmacol; 2003 Jun; 18(4):301-9. PubMed ID: 12766935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine].
    Gram LF
    Ugeskr Laeger; 2000 Mar; 162(13):1914-5. PubMed ID: 10765710
    [No Abstract]   [Full Text] [Related]  

  • 17. Atypical neuroleptic malignant syndrome?
    Haggarty JM; Husni M; Peat C; Allain S
    Can J Psychiatry; 1999 Sep; 44(7):711-2. PubMed ID: 10500880
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroleptic malignant syndrome after addition of haloperidol to atypical antipsychotic.
    Mujica R; Weiden P
    Am J Psychiatry; 2001 Apr; 158(4):650-1. PubMed ID: 11282706
    [No Abstract]   [Full Text] [Related]  

  • 19. Finding drug link to reaction.
    Hammond C
    Am J Health Syst Pharm; 1999 Aug; 56(15):1558-9. PubMed ID: 10478998
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
    Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M
    W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.